Mirion Technologies, Inc. MIR
At Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. For more than 60 years Mirion and our predecessor companies have provided products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. As a global leader in the field of radiation safety and innovation, we bring together unrivaled expertise with an unmatched range of reliably precise technologies.
Safety is at the core of what we do. Through critical nuclear facilities, R&D labs, cancer centers, diagnostic imaging facilities, and on the front lines, Mirion empowers innovations that move radiation safety, measurement and medicine further to shape our future world. Many of our markets are characterized by the need to meet rigorous regulatory standards, design qualifications, and operating requirements. Throughout our history, we have successfully leveraged the strength of our expertise to continually drive innovation and expand the commercial applications of our core technology competencies.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $925.4M | $860.8M | $800.9M | $717.8M | $611.6M | $478.2M | $440.1M | — | — |
| Cost of revenue | $486.8M | $461.1M | $444.5M | $407.7M | $359.8M | $281.2M | $251.9M | — | — |
| Gross profit | $438.6M | $399.7M | $356.4M | $310.1M | $251.8M | $197.0M | $188.2M | — | — |
| R&D | $38.9M | $35.0M | $31.7M | $30.3M | $29.4M | $15.9M | $14.0M | — | — |
| SG&A | $348.2M | $341.1M | $340.1M | $362.3M | $211.2M | $158.1M | $145.4M | — | — |
| Total operating expenses | $387.1M | $374.9M | $378.3M | $607.9M | $240.6M | $174.0M | $159.4M | — | — |
| Operating income | $51.5M | $24.8M | -$21.9M | -$297.8M | $11.2M | $23.0M | $28.8M | — | — |
| Interest expense | $42.2M | $57.9M | $61.9M | — | — | — | — | — | — |
| Pre-tax income | $32.7M | -$33.9M | -$105.3M | -$306.6M | -$164.3M | -$124.6M | -$126.2M | — | — |
| Income tax | $2.9M | $2.7M | $6.6M | $18.2M | $5.9M | $5.5M | $4.2M | — | — |
| Net income | $28.8M | -$36.1M | -$96.9M | -$276.9M | -$158.3M | -$119.1M | -$122.0M | -$295 | — |
| EPS, basic | 0.13 | -0.18 | -0.49 | -1.53 | -24.18 | -18.45 | -19.36 | — | — |
| EPS, diluted | 0.11 | -0.18 | -0.49 | -1.53 | -24.18 | -18.45 | -19.36 | — | — |
| Shares, diluted (wtd. avg.) | $261.2M | $205.0M | $196.4M | $181.1M | $6.5M | $6.5M | $6.3M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $412.3M | $175.2M | $128.8M | $75.0M | $85.3M | $120.0M | $37.6M | $35.9M | $0 |
| Receivables | $181.6M | $177.7M | $172.3M | $171.2M | $133.3M | $97.3M | — | — | — |
| Inventory | $152.6M | $133.2M | $144.1M | $143.3M | $113.2M | $90.2M | — | — | — |
| Total current assets | $893.7M | $594.7M | $538.6M | $480.6M | $433.9M | $389.7M | $5.0K | — | — |
| Property, plant and equipment | $154.9M | $146.3M | $134.5M | $124.3M | $88.8M | $75.2M | — | — | — |
| Goodwill | $1.87B | $1.43B | $1.45B | $1.42B | $1.66B | $522.6M | $511.6M | — | — |
| Other intangibles | $606.3M | $411.6M | $538.8M | $650.4M | $326.3M | $248.3M | — | — | — |
| Total assets | $3.59B | $2.64B | $2.72B | $2.74B | $1.55B | $1.24B | $5.0K | — | — |
| Accounts payable | $57.4M | $56.5M | $58.7M | $67.7M | $47.1M | $38.7M | $636 | — | — |
| Short-term debt | $1.6M | $1.2M | $1.2M | $5.3M | $6.4M | $41.1M | — | — | — |
| Total current liabilities | $316.1M | $263.4M | $265.7M | $244.3M | $188.2M | $183.5M | $636 | — | — |
| Long-term debt | $443.1M | $685.2M | $684.7M | $801.5M | $885.7M | $669.8M | — | — | — |
| Total liabilities | $1.67B | $1.08B | $1.17B | $1.27B | $2.39B | $1.96B | $636 | — | — |
| Retained earnings | -$512.7M | -$541.5M | -$505.4M | -$408.5M | -$888.0M | -$729.7M | -$636 | — | — |
| Total equity | $1.87B | $1.51B | $1.55B | $1.47B | $1.78B | -$716.5M | -$587.7M | -$448.8M | $0 |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $143.3M | $99.1M | $95.2M | $39.4M | $53.6M | $39.5M | $14.7M | $0 | — |
| Depreciation and amortisation | $138.1M | $150.4M | $162.8M | $174.5M | $83.6M | $68.4M | — | — | — |
| Stock-based compensation | $15.2M | $15.6M | $21.9M | $31.8M | $0 | $200.0K | $100.0K | — | — |
| Capital expenditure | $36.4M | $48.8M | $37.1M | $34.2M | $23.2M | $19.9M | $16.5M | — | — |
| Investing cash flow | -$694.6M | -$43.7M | -$64.7M | -$39.5M | -$313.3M | -$75.6M | -$25.6M | — | — |
| Financing cash flow | $775.9M | -$3.3M | $22.6M | -$7.0M | $239.0M | $118.9M | $15.0M | $5.0K | — |
| Buybacks | $49.6M | $0 | $0 | $0 | $0 | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001628280-26-009869.
Others in SIC 3829
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC. | $226.94B | 34.6x | 3.9% |
| ROK | ROCKWELL AUTOMATION, INC | $48.17B | 56.6x | 0.9% |
| TRMB | TRIMBLE INC. | $13.87B | 33.8x | -2.6% |
| ONTO | ONTO INNOVATION INC. | $13.15B | 96.4x | 1.8% |
| QSI | Quantum-Si Inc | $166.8M | — | -20.3% |
| OWLT | Owlet, Inc. | $145.5M | — | 35.4% |
| GEOS | GEOSPACE TECHNOLOGIES CORP | $69.6M | — | -18.3% |
| BCHT | Birchtech Corp. | $31.3M | — | 1.3% |